UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

The New England journal of medicine, 2015-08, Vol.373 (8), p.737-746

2015

Volltextzugriff (PDF)

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1080-1087

2018

Volltextzugriff (PDF)

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

The Journal of urology, 2021-01, Vol.205 (1), p.14-21

2021

Volltextzugriff (PDF)

Therapy-Induced Senescence in Cancer

JNCI : Journal of the National Cancer Institute, 2010-10, Vol.102 (20), p.1536-1546

2010

Volltextzugriff (PDF)

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

European urology, 2018-06, Vol.73 (6), p.847-855

2018

Volltextzugriff (PDF)

Toward the Detection of Prostate Cancer in Urine: A Critical Analysis

The Journal of urology, 2013-02, Vol.189 (2), p.422-429

2013

Volltextzugriff (PDF)

Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches

The Journal of urology, 2019-05, Vol.201 (5), p.101097JU0000000000000117-885

2019

Volltextzugriff (PDF)

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

The Journal of urology, 2018-12, Vol.200 (6), p.1264-1272

2018

Volltextzugriff (PDF)

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II

The Journal of urology, 2021-01, Vol.205 (1), p.22-29

2021

Volltextzugriff (PDF)

Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)

The Journal of urology, 2023-06, Vol.209 (6), p.1082-1090

2023

Volltextzugriff (PDF)

Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?

Urologic clinics of North America, 2017-11, Vol.44 (4), p.611-621

2017

Volltextzugriff (PDF)

HyPR-MS for Multiplexed Discovery of MALAT1, NEAT1, and NORAD lncRNA Protein Interactomes

Journal of proteome research, 2018-09, Vol.17 (9), p.3022-3038

2018

Volltextzugriff (PDF)

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy

PloS one, 2017-02, Vol.12 (2), p.e0172048

2017

Volltextzugriff (PDF)

Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy

The Journal of urology, 2018-12, Vol.200 (6), p.1256-1263

2018

Volltextzugriff (PDF)

Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer

Journal of clinical oncology, 2018-04, Vol.36 (11), p.1088-1095

2018

Volltextzugriff (PDF)

Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection

PloS one, 2019-06, Vol.14 (6), p.e0218950-e0218950

2019

Volltextzugriff (PDF)

Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion

Urology (Ridgewood, N.J.), 2024-02, Vol.184, p.272-277

2024

Volltextzugriff (PDF)

Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform

The FASEB journal, 2022-10, Vol.36 (10), p.e22540-n/a

2022

Volltextzugriff (PDF)

Elucidating the RNA–Protein Interactomes of Target RNAs in Tissue

Analytical chemistry (Washington), 2023-05, Vol.95 (18), p.7087-7092

2023

Volltextzugriff (PDF)

The Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes

Urology (Ridgewood, N.J.), 2023-12, Vol.182, p.175-180

2023

Volltextzugriff (PDF)

A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation

PloS one, 2014-02, Vol.9 (2), p.e88052

2014

Volltextzugriff (PDF)

Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression

Human pathology, 2014-05, Vol.45 (5), p.1092-1099

2014

Volltextzugriff (PDF)

Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes

BMC cancer, 2017-12, Vol.17 (1), p.874-874, Article 874

2017

Volltextzugriff (PDF)

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Oncotarget, 2023-07, Vol.14 (1), p.738-746

2023

Volltextzugriff (PDF)

Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence

PloS one, 2015-04, Vol.10 (4), p.e0124366-e0124366

2015

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(359)
Mit Volltextzugriff
(235)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(396)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(127)
The journal Of Urology/the journal Of Urology
(43)
Journal Of Clinical Oncology
(26)
Cancer Research
(19)
The Prostate
(16)
Urology
(15)
Urologic Oncology
(14)
Trustee
(9)
Plos One
(7)
American Journal Of Clinical And Experimental Urology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I

Therapy-Induced Senescence in Cancer

Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies

Toward the Detection of Prostate Cancer in Urine: A Critical Analysis

Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches

Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II

Updates to Advanced Prostate Cancer: AUA/SUO Guideline (2023)

Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?

HyPR-MS for Multiplexed Discovery of MALAT1, NEAT1, and NORAD lncRNA Protein Interactomes

Persistence of senescent prostate cancer cells following prolonged neoadjuvant androgen deprivation therapy

Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy

Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer

Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection

Shorter Ureters Lead to Fewer Strictures Following Cystectomy and Urinary Diversion

Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform

Elucidating the RNA–Protein Interactomes of Target RNAs in Tissue

The Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes

A novel pathway links oxidative stress to loss of insulin growth factor-2 (IGF2) imprinting through NF-κB activation

Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression

Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells

Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence

Suchergebnisse filtern